Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 30:38:100825.
doi: 10.1016/j.gore.2021.100825. eCollection 2021 Nov.

Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing

Vera M Witjes  1 , Janet R Vos  2 , Marjolijn J L Ligtenberg  1   3 , Nicoline Hoogerbrugge  1
Affiliations

Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing

Vera M Witjes et al. Gynecol Oncol Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Lin J., et al. Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis. Gynecol. Oncol. 2021 doi: 10.1016/j.ygyno.2021.05.011. - DOI - PMC - PubMed
    1. McCuaig J.M., et al. Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system. Gynecol. Oncol. 2020;158(3):747–753. doi: 10.1016/j.ygyno.2020.06.507. - DOI - PubMed
    1. Vos J.R., et al. Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition. JNCI: J. Natl. Cancer Inst. 2019;112(2):161–169. doi: 10.1093/jnci/djz080. - DOI - PMC - PubMed

LinkOut - more resources